跳至主要内容
临床试验/NCT06907537
NCT06907537已完成不适用

A Study to Verify the Sleep-improving Effects of the Test Food Consumption: a Randomized, Placebo-controlled, Double-blind, Parallel-group Comparison Study

Orthomedico Inc.4 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2025年4月3日最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
44
试验地点
4
主要终点
The measured value of Zc score of "sleepiness on rising" in the OSA sleep inventory MA version (OSA-MA) after the 12-week intervention

研究概览

简要总结

The goal of this clinical trial is to test in Japanese adults who feel sleepy when they wake up. The question it aims to answer are:

•Does taking plasmalogens reduce sleepiness upon waking?

Participants will be given the following tasks:

  • Take 4 capsules daily containing plasmalogens for 12 weeks.
  • Answer the questionnaire on sleepiness1 when they wake up.
  • Answer the questionnaire on daytime sleepiness2. Researchers will compare plasmalogens and placebo groups to see if plasmalogens reduce sleepiness upon waking.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men or women
  • Healthy individuals
  • Individuals whose Zc score of "sleepiness on rising" is relatively low at screening

排除标准

  • Individuals who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, or myocardial infarction
  • Individuals who have a pacemaker or an implantable cardioverter defibrillator (ICD)
  • Individuals who are currently undergoing treatment of any of the following chronic diseases: cardiac arrhythmia, liver disorder, chronic kidney disease, cerebrovascular disorder, rheumatic disease, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases
  • Individuals who are undergoing medical treatment or have a medical history of any of the following diseases: mental disorders (e.g., depression), sleep apnea syndrome, hypersomnia, narcolepsy, insomnia, or valvular heart disease
  • Individuals who have habits of consuming foods or using devices to improve sleep
  • Individuals who have irregular sleeping habits due to lifestyle such as night shifts
  • Individuals who fall under the following sleeping conditions: sleeping in the same room with two or more people, living with preschool-aged children, living with individuals who require nursing care, or having their sleep potentially disturbed by the influence of others
  • Individuals who have nocturia two times or more
  • Individuals who usually drink to excess (average of more than about 20 g/day as absolute alcohol intake) {500 mL: a medium bottle of beer or about 1.5 cans of canned chu-hi, 180 mL: 1 go of sake or about 1.5 glasses of wine, 90 mL: half-go with shochu, 60 mL: a glass of whiskey brandy (double)}
  • Individuals who are taking "Foods for Specified Health Uses" or "Foods with Functional Claims"
  • Individuals who are taking medications (including herbal medicines) or supplements
  • Individuals who are allergic to medicines or foods related to the test product, or have a gelatin allergy or sea squirt-induced asthma
  • Individuals who are pregnant, lactating, or planning to become pregnant during this study
  • Individuals who have been enrolled in other clinical studies within the last 28 days before the agreement to participate in this study or plan to participate in another study during this study
  • Individuals who are judged as ineligible to participate in this study by the physician

结局指标

主要结局

The measured value of Zc score of "sleepiness on rising" in the OSA sleep inventory MA version (OSA-MA) after the 12-week intervention

时间窗: After the 12-week intervention

The OSA-MA is used to assess sleep quality. Individuals are asked to complete the questionnaire immediately after waking on the examination day and two days before the examination. The raw scores from each examination day will be converted to Zc scores, and the three-day mean, rounded to one decimal place, will be used as the measured value. "Sleepiness on rising" consists of four questions. Higher score indicates better outcome.

次要结局

  • The measured value of Zc score of "sleepiness on rising" in the OSA-MA after the 6-week intervention(After the 6-week intervention)
  • The measured values of Zc score of "initiation and maintenance of sleep," "frequent dreaming," "refreshing," and "sleep length" in the OSA-MA after the 6 and12-week intervention(After the 6 and12-week intervention)
  • The measured value of total score of the Athens Insomnia Scale (AIS) after the 6 and12-week intervention(After the 6 and12-week intervention)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验